A 48-year-old woman with a structurally normal heart presents with palpitations and syncope. Electrophysiologic study reveals a ventricular arrhythmia arising from the right ventricular outflow tract (RVOT). Which feature most reliably distinguishes idiopathic RVOT VT from scar-related monomorphic VT in a post-MI patient?

Explanation

## Idiopathic RVOT VT vs. Scar-Related Monomorphic VT ### Clinical Context and Distinction **Key Point:** Idiopathic RVOT VT and scar-related monomorphic VT are both monomorphic arrhythmias, but they differ fundamentally in **mechanism, substrate, and pharmacologic response**. The most reliable **clinical discriminator** is the **response to adenosine and beta-blockers**. ### Comparison Table | Feature | Idiopathic RVOT VT | Scar-Related Monomorphic VT | |---------|---|---| | **Substrate** | Structurally normal heart | Prior MI with scar | | **Mechanism** | Triggered activity (DAD) / automaticity | Re-entry (fixed circuit) | | **Adenosine Response** | **Terminates or suppresses** | Resistant (no response) | | **Beta-Blocker Response** | **Suppresses or terminates** | Suppresses but does not terminate | | **Inducibility by PES** | Often non-inducible or difficult | Easily inducible | | **Morphology** | Monomorphic, LBBB pattern with inferior axis | Monomorphic, variable morphology based on scar location | | **Cardiac Imaging** | Normal LV function, no scar | Scar on CMR or echo | | **Prognosis** | Generally benign | High risk of sudden death | ### Why Adenosine/Beta-Blocker Response is the Discriminator **High-Yield:** Idiopathic RVOT VT is **triggered** (usually by delayed afterdepolarization, DAD) or **automatic**. These mechanisms are **adenosine-sensitive and beta-blocker-sensitive** because they depend on cAMP-mediated calcium handling and autonomic tone. **Adenosine terminates or suppresses the arrhythmia in >80% of idiopathic RVOT VT cases**. In contrast, scar-related monomorphic VT is **re-entrant** — it requires a fixed anatomic circuit (scar tissue with slow conduction). Re-entrant circuits are **adenosine-resistant** because adenosine does not disrupt the fixed anatomic pathway; it may slow conduction slightly but does not terminate the arrhythmia. **Clinical Pearl:** At the bedside or in the EP lab, **IV adenosine (6–12 mg rapid push) is a diagnostic tool**: if the VT terminates abruptly, idiopathic RVOT VT is likely; if there is no response, scar-related VT is more probable. This is faster and more practical than waiting for cardiac imaging or PES results. ### Mechanism Basis ```mermaid flowchart TD A[Monomorphic VT]:::outcome --> B{Adenosine-sensitive?}:::decision B -->|Yes, terminates| C[Triggered/Automatic]:::outcome C --> D[Idiopathic RVOT VT]:::action D --> E[Normal cardiac structure]:::outcome B -->|No response| F[Re-entrant]:::outcome F --> G[Scar-Related VT]:::action G --> H[Prior MI, scar on imaging]:::outcome ``` ### Why Other Options Are Suboptimal **Key Point:** While **scar presence on cardiac imaging** is a defining feature of scar-related VT, it is not a discriminator in the acute clinical setting — imaging takes time and may not be immediately available. Adenosine response is immediate and actionable. **Inducibility by PES** is also not a reliable discriminator: both idiopathic RVOT VT and scar-related VT can be inducible, depending on the specific arrhythmia and stimulation protocol. Idiopathic RVOT VT is often **non-inducible** or requires isoproterenol infusion, but this is not a universal rule. **Monomorphic morphology** is present in both — it is not discriminatory. ### Management Implications - **Idiopathic RVOT VT:** Beta-blockers or verapamil as first-line; catheter ablation if refractory. - **Scar-Related VT:** ICD for primary prevention; antiarrhythmic drugs (amiodarone, sotalol); ablation for incessant VT. [cite:Harrison 21e Ch 235]